Arterra Bioscience S.p.A. (BIT:ARBS)

Italy flag Italy · Delayed Price · Currency is EUR
2.700
-0.100 (-3.57%)
At close: Mar 13, 2026
Market Cap17.98M +36.4%
Revenue (ttm)4.17M +25.1%
Net Income1.34M +24.2%
EPS0.20 +24.2%
Shares Out6.66M
PE Ratio13.45
Forward PEn/a
Dividend0.13 (4.81%)
Ex-Dividend DateMay 5, 2025
Volume12,000
Average Volume6,975
Open2.720
Previous Close2.800
Day's Range2.700 - 2.780
52-Week Range1.890 - 3.580
Beta0.80
RSI30.13
Earnings DateMar 30, 2026

About Arterra Bioscience

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 34
Stock Exchange Borsa Italiana
Ticker Symbol ARBS
Full Company Profile

Financial Performance

In 2024, Arterra Bioscience's revenue was 4.17 million, an increase of 25.08% compared to the previous year's 3.34 million. Earnings were 1.34 million, an increase of 24.21%.

Financial Statements